ORIGINAL RESEARCH ARTICLE


https://doi.org/10.5005/jp-journals-10055-0124
Current Trends in Diagnosis and Treatment
Volume 5 | Issue 1 | Year 2021

Intravenous Clonidine with Lignocaine Nebulization to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation: A Comparative Study

Manbir Kaur1, Anita Kumari2, Sunil Chawla3, Ruchi Gupta4

1,3,4Department of Anaesthesia, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India

2Department of Anaesthesia and Critical Care, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India

Corresponding Author: Anita Kumari, Department of Anaesthesia and Critical Care, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India, Phone: +91 9815632909, e-mail: kumarianitadr1@gmail.com

How to cite this article: Kaur M, Kumari A, Chawla S, et al. Intravenous Clonidine with Lignocaine Nebulization to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation: A Comparative Study. AMEI’s Curr Trends Diagn Treat 2021;5(1):26–30.

Source of support: Nil

Conflict of interest: None

ABSTRACT

Introduction: The present study was conducted to compare the efficacy of intravenous (i.v.) clonidine with that of lignocaine nebulization for attenuation of pressor response to laryngoscopy and tracheal intubation.

Materials and methods: Fifty patients of either sex aged between 18 years and 60 years covered under American Society of Anesthesiologists health status classes I and II, undergoing elective surgery under general anesthesia requiring endotracheal intubation, were considered. Patients were randomly divided into two groups. Group A received i.v. clonidine 1 μg per kg and nebulization with 3 mg per kg of 4% lignocaine, and group B received i.v. normal saline and nebulization with 3 mg per kg of 4% lignocaine before intubation. Hemodynamic parameters were noted at baseline, after giving study drug, every minute after intubation for 10 minutes and then every 10 minutes thereafter till the end of the surgery.

Results: It was noted that in group A, the rise of HR, SBP, DBP, and MAP 1 minute after intubation was found to be 85.4 bpm, 117.5, 70.6, and 86.2 mm Hg, and in group B, the rise of HR, SBP, DBP, and MAP 1 minute after intubation was found to be 93.9 bpm, 129.9, 85.2, and 100.1 mm Hg, respectively. Nebulized lignocaine was not found effective in attenuating hemodynamic response to intubation, and hemodynamic parameters were significantly high after intubation as compared to clonidine group.

Conclusion: In our study, i.v. clonidine in a dose of 1 µg per kg administered 15 minutes before laryngoscopy, and intubation was far superior to nebulized lignocaine alone in attenuation of the hemodynamic response.

Keywords: Clonidine, Hemodynamic response, Intubation, Laryngoscopy, Lignocaine, Nebulization.

INTRODUCTION

When general anesthesia is administrated, the most critical events occur during laryngoscopy and endotracheal intubation. Hypertension occurs due to marked provocation of sympathoadrenal system causing rise in plasma catecholamine as tachycardia and hypertension. The circulatory responses have been reported immediately following laryngoscopy and intubation with a mean increase in systolic arterial pressure of 40 mm Hg even in normotensive individuals.1 It starts within 5 seconds, reaches a peak in 1–2 minutes, and returns to baseline within 5 minutes.2

The sympathoadrenal activity leads to an increase in plasma catecholamine levels, which may result in ailments, like hypertension, tachycardia, and arrhythmias.3 The response is usually transient and unpredictable. Only healthy individuals can very well sustain this response, but hazardous in patients with comorbidities, like hypertension, myocardial insufficiency, and cerebrovascular diseases.4 The laryngoscopic reaction in these patients may render them to development of myocardial infarction, acute left ventricular failure (LVF), dysrhythmias, and intracranial bleed.

Various methods have been devised to blunt this pressor response elicited by upper-airway irritation, but no single agent has been yet able to be considered as most appropriate for this purpose. Some authors tried the use of intravenous (i.v.) lignocaine, laryngotracheal instillation of lignocaine, opioids, deep inhalational anesthesia, β-blockers, and magnesium sulfate before initiating laryngoscopy.59

It was hypothesized that topical anesthesia of airway alone or in combination with other techniques may be useful in suppressing the hemodynamic response to laryngoscopy and intubation. Administration of lignocaine via nebulizer produces low serum levels and reduces adverse effects compared to gel or spray formulations.

Our objective was to find a simple and safe method for diminishing the stress response, particularly in compromised patients with decreased myocardial reserve. Intravenous clonidine, an α-2 adrenergic agonist, appears to obtund the stress response to the surgical stimuli.10 Hence, this study was designed to compare the efficacies of i.v. clonidine and lignocaine nebulization in attenuating the hemodynamic response to laryngoscopy and tracheal intubation.

MATERIALS AND METHODS

The present study was conducted in a prospective, randomized, interventional, and double-blind comparative manner in the Department of Anaesthesia, a Tertiary Care Medical Institute, Sri Amritsar, after taking written informed consent of patient and approval by Hospital Ethical Committee. A total of 50 American Society of Anesthesiologists (ASA) classes I–II adult patients in the age group of 18–60 years belonging to either sex admitted for elective surgery under general anesthesia were studied.

Group size of the study has been determined as 44 by considering α error of 0.05 and power of study of 80%. Considering 10% dropout rate, the sample size has been increased to 50 with 25 patients in each group.

Computer-generated random number was obtained and sealed in envelope. The slip was taken out by the senior anesthesiologist not involved in the study, and drug was prepared according to the coded slip.

The patient and the observer were blind to the drug solution injected, and the drug solution was in the form of 10-mL solution each. Group A received i.v. clonidine 1 µg per kg (diluted to 10 cc with normal saline) and nebulization with 3 mg per kg (0.075 mL per kg) of 4% lignocaine and group B received i.v. normal saline 10 cc and nebulization with 3 mg per kg (0.075 mL/kg) of 4% lignocaine. The study drugs were administered 15 minutes prior to intubation.

Patients with the following conditions were excluded from the study: not willing to participate, anticipated and unanticipated difficult airway, hypertension, ischemic heart disease, known allergy to study drugs, patients requiring >30 seconds or more than one attempt for laryngoscopy, occurrence of laryngospasm or bronchospasm, and patients receiving antihypertensives, sympathomimetics, antidepressants, vagomimetics, etc.

A thorough preoperative assessment of the patient was done by an anesthesiologist. All patients were investigated for complete blood count, renal function test, electrocardiogram (ECG), and chest X-ray.

All patients in the study received a standard general anesthesia technique followed by endotracheal intubation. Patients received tab. alprazolam 0.5 mg at night and at 6 a.m. on the day of surgery. Intraoperative monitoring including ECG, pulse oximeter, noninvasive blood pressure, and reading thus obtained were considered baseline.

All the patients received 3 mg per kg (0.075 mL/kg) of 4% lignocaine by nebulization with O2. Nebulization was done until the complete utilization of the drug. After that, the patients, according to the allotted groups, received i.v. clonidine 1 µg per kg diluted to 10 cc with normal saline or i.v. normal saline 10 cc given slowly 15 minutes prior to intubation.

Inj. glycopyrrolate (0.2 mg) and inj. butorphanol (1 mg) were given at the time of induction. Preoxygenation with 100% O2 was done for 3 minutes. Intravenous induction was done using propofol 2 mg per kg and succinylcholine (1–1.5 mg/kg). Laryngoscopy was done after 15 minutes of giving the study drug. Patient was intubated with an appropriate sized cuffed endotracheal tube by an experienced anesthesiologist. After checking the ventilation, anesthesia was maintained with 60% nitrous oxide in oxygen along with isoflurane and vecuronium.

Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), oxygen saturation (SpO2), and ECG were recorded at baseline, just before intubation, every minute after intubation for 10 minutes and then every 10 minutes thereafter till the end of the surgery. Any untoward incident in the form of coughing and bucking was recorded.

During the study period of 10 minutes after intubation, the occurrence of hypotension (fall in SBP >20% from baseline), hypertension (rise in SBP >20% from baseline), bradycardia (fall in HR >20% from baseline), tachycardia (rise in HR >20% of baseline), arrhythmias, and ST–T changes were noted and treated. Inj. mephenteramine 6 mg was given when SBP <90 mm Hg. Inj. atropine was given when HR <60 beats per minute.

At the end of the surgery, the anesthetic gas mixture was replaced with 100% oxygen to facilitate patient recovery. Patients were extubated after giving inj. neostigmine 50 µg per kg and glycopyrrolate 10 µg per kg. After extubation, patients were shifted to recovery room.

Side effects of the study drugs, such as xerostomia, drowsiness, skin rash, constipation, dry eyes, dizziness, and headache, were recorded and treated accordingly.

Statistical Analysis

The data from the present study were systematically collected, compiled, and statistically analyzed with SPSS Statistics 26 version to draw relevant conclusions. The observations were tabulated in the form of mean ± standard deviation. For association between categorical variables, Chi-square test was applied. For parametric data, Student t-test was used. The level of significance was determined as p-values p <0.05 and p <0.01 as significant and p <0.001 as highly significant.

RESULTS

Demographic Profile

Age, sex, weight, ASA physical status, height, and duration of surgery were comparable in both the groups (p >0.05) (Table 1).

Baseline hemodynamic parameters were comparable in both the groups (p >0.05).

The maximum increase in HR was seen in group B 1 minute after intubation (Fig. 1). When HR at different time intervals in group B was compared with that in group A, it was found to be significantly high (p <0.001) in group B 1 minute after intubation and remained increased till 6 minutes after intubation.

On comparing SBP and DBP in group A with those in group B at different time intervals, SBP and DBP in group B were significantly high (p <0.001) from 1 minute after intubation and slightly reduced thereafter but remained high when compared to group A (Figs 2 and 3).

MAP was maximally increased after intubation in group B (Fig. 4).

MAP was significantly high (p <0.001) in group B from 1 minute after intubation and increased up to 2 minutes when compared with group A.

The maximum increase in hemodynamic parameters in both the groups was observed at 1 minute after intubation. Group B showed significantly greater increase (p <0.001) in all the hemodynamic parameters when compared with group A.

Coughing was not observed in any patient at the time of laryngoscopy and intubation. ECG was within normal limits in all the patients studied during the study period. No episodes of dysrhythmias in any patient were observed. No patient required atropine or vasopressor. There was not any episode of fall in SpO2 levels during the study period.

Hypotension was seen in three cases in group A and was treated with i.v. fluids and inj. mephenteramine 6 mg i.v. bolus. No hypotension was noted in group B. No side effects of study drugs were seen in both the groups.

Table 1: Demographic characteristics
Group A (n = 25) Group B (n = 25) p value
Age (years) 38.52 ± 10.47 37.72 ± 11.8 0.801
Height (cm) 161.92 ± 6.92 166.12 ± 9.58 0.082
Weight (kg) 66.48 ± 7.63 69.24 ± 7.75 0.211
Duration of surgery (min) 89.2 ± 2.77 88.8 ± 3.32 0.646
ASA (I/II) 19/6 17/8 0.529
Gender (M/F) 16/9 15/10 0.089

Fig. 1: Comparison of intraoperative mean heart rate (bpm) at various time intervals

Fig. 2: Comparison of intraoperative mean systolic blood pressure (mm Hg) at various time intervals

Fig. 3: Comparison of intraoperative diastolic blood pressure (mm Hg) at various time intervals

Fig. 4: Comparison of intraoperative mean arterial pressure (mm Hg) at various time intervals

DISCUSSION

Hemodynamic response to laryngoscopy and intubation was not completely abolished in both the groups. Clonidine was much more effective in blunting the postintubation increase in both HR and blood pressures than nebulized lignocaine.

Soni et al., Cordeiro and D’Souza, and Arora et al. also found i.v. clonidine effective in blunting hemodynamic response to intubation.1113 Marulasiddappa and Nethra in their study compared i.v. clonidine 2 µg per kg with i.v. lignocaine 1.5 mg per kg and found decrease of mean HR which remained below baseline at all times in the clonidine group.14 Kalra et al. showed that the preoperative administration of clonidine reduced the sympathoadrenal response and improved the hemodynamic stability with no consequential hypotension.15

Charan et al. observed the mean MAP was below the baseline value in the clonidine group. All the above findings were comparable to our study.16

Kulka et al. concluded that i.v. clonidine in a dose of 4 µg per kg significantly attenuated the hemodynamic and adrenergic reactions to stress response to laryngoscopy in coronary artery bypass grafting (CABG) patients, but side effects limiting the use of i.v. clonidine were observed. This may be due to a higher dose of clonidine used in their study, unlike our study in which we used 1 µg per kg.17

Nebulized lignocaine was not effective as all the hemodynamic parameters were significantly increased after intubation when compared with clonidine group.

Chinn et al. in their study demonstrated that up to 60% of lignocaine dose can be lost via nebulized route. The findings showed that a major part of the drug is lost to air and in patient’s mouth during nebulization. The inhalation method provides inadequate anesthesia of upper airway. Also it has been suggested that nebulized lignocaine partially inhibits the vagus afferent which may result in unopposed sympathetic outflow with increase in HR and blood pressure.18 These results were consistent with the studies done by Laurito et al. and Bunting et al.19,20

Similar results were also found by Kumar et al., who concluded that nebulized lignocaine as least effective in attenuating hemodynamic response.21 Meng et al. found topical lignocaine and ropivacaine effective in reducing hemodynamic responses during intubation and ropivacaine better at inhibiting hemodynamic changes at emergence in hypertensive patients when compared with lignocaine.22

Contrary to our findings, Jokar et al. concluded that inhaled lignocaine 4% 75 mg per kg can control hemodynamic response more effectively.23 Ganesan et al. observed that nebulization with 8 mL of 2% lignocaine 20 minutes before laryngoscopy is more effective than i.v. lignocaine.24

In our study, hypotension was seen in four cases in group A and no hypotension in group B. Charan et al. observed that in clonidine group (1 µg/kg), 15 out of 50 patients had hypotension, which was treated by rapid i.v. fluids, and 3 out of 50 patients developed bradycardia.16 Arora et al. showed that hypotension was seen in both the clonidine premedicated groups (1 and 2 µg/kg) given 10 minutes prior to induction and treated by ephedrine 6 mg i.v. bolus.13

Contrary to the above findings, Acharya and Routray and Marulasiddappa and Nethra noticed that no side effects, such as hypotension and bradycardia, were observed in any of the patients when clonidine was given in the dose of 3 and 2 µg per kg, respectively.25,14

Acharya and Routray and Chhatrapati and Shitole found that clonidine in a dose of 3 µg per kg caused adequate sedation without respiratory depression, whereas in our study, sedation was not seen in any patient.25,26

CONCLUSION

To conclude, i.v. clonidine in a dose of 1 µg per kg administered 15 minutes before laryngoscopy and intubation was far superior to nebulized lignocaine alone in attenuation of the hemodynamic response.

REFERENCES

1. King BD, Harris LC, Greifenstein FE, et al. Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed during general anesthesia. Anesthesiology 1951;12(5):556–566. DOI: 10.1097/00000542-195109000-00002.

2. Henderson J. Airway management in the adult. In: Miller RD, editor. Miller’s anesthesia. 7th ed. Philadelphia: Elsevier Churchill Livingstone; 2010. p. 1573–1610.

3. Prys-Robers C, Greene LT, Meloche R, et al. Studies of anaesthesia in relation to hypertension-II. Haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth 1971;43(6):531–547. DOI: 10.1093/bja/43.6.531.

4. Kovac AL. Controlling the haemodynamic response to laryngoscopy and endotracheal intubation. J Clinical Anesthesiol 1996;8(1):63–79. DOI: 10.1016/0952-8180(95)00147-6.

5. Stoelting RK. Blood pressure and heart rate changes during short duration laryngoscopy for tracheal intubation: influence of viscous or intravenous lignocaine. Anaesth Analg 1978;57(2):197–199. DOI: 10.1213/00000539-197803000-00009.

6. Dahlgreen N, Messeter K. Treatment of the stress response to laryngoscopy and intubation with fentanyl. Anaesthesia 1981;36(11):1022. DOI: 10.1111/j.1365-2044.1981.tb08676.x.

7. Chung KS, Sinatra RS, Chung JH. The effect of an intermediate dose of labetalol on heart rate and blood pressure responses to laryngoscopy and intubation. J Clin Anaesth 1992;4(1):11–15. DOI: 10.1016/0952-8180(92)90112-e.

8. Bhushanam Padala SA, Anakapalli M, Mangu HR, et al. Effect of sevoflurane with morphine or fentanyl on haemodynamic response to laryngoscopy and tracheal intubation: a prospective, randomised, double-blind study. J Clin Sci Res 2018;7(2):58–63. DOI: 10.4103/JCSR.JCSR_31_18.

9. MontazeriI K, Falah M. Dose-response study: MgSO4 in cardiovascular responses after laryngoscopy and endotracheal intubation. Canadian J Anesth 2005;52(S1):80. DOI: 10.1007/BF03023167.

10. Stoelting RK, Hiller SC. Antihypertensive drugs. In: Brain B, Frain M, editors. Pharmacology and physiology in anaesthetic practice. 4th ed. Philadelphia: Lippincott Williams and Wilkins Publishers; 2006. p. 343.

11. Soni B, Sheth P, Kapadia K. Comparative study of intravenous infusion of clonidine and/or magnesium sulphate on haemodynamic stress response to tracheal intubation and pneumoperitoneum during laparoscopic surgery. Natl J Med Res 2017;7(1):22–25.

12. R Cordeiro, SA D’Souza. Intravenous 2 μg/kg clonidine in comparison to intravenous 2 μg/kg fentanyl for attenuation of haemodynamic response to laryngoscopy and orotracheal intubation. J Evol Med and Dent Sci 2016;5(26):1366–1371. DOI: 10.14260/jemds/2016/322.

13. Arora S, Kulkarni A, Bhargava AK. Attenuation of hemodynamic response to laryngoscopy and endotracheal intubation using intravenous clonidine. J Anaesthesiol Clin Pharmacol 2015;31(1):110–114. DOI: 10.4103/0970-9185.150559.

14. Marulasiddappa V, Nethra HN. A comparative study of clonidine and lignocaine for attenuating pressor responses to laryngoscopy and tracheal intubation in neurosurgical cases. Anesth Essays Res 2017;11(2):401–405. DOI: 10.4103/0259-1162.194557.

15. Kalra NK, Verma A, Agarwal A. Comparative study of intravenously administered clonidine and magnesium sulphate on haemodynamic response during laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol 2011;27(3):344–348. DOI: 10.4103/0970-9185.83679.

16. Charan N, Hijam B, Ninave S, et al. A double blind comparative study of IV clonidine and fentanyl to see the haemodynamic response during laryngoscopy and intubation. J Evol Med Dent Sci 2014;3(39):10015–10025. DOI: 10.4103/0259-1162.194557.

17. Kulka PJ, Tryba M, Zenz M. Dose-response effects of intravenous clonidine on stress response during induction of anaesthesia in coronary artery bypass graft patients. Anaesth Analg 1995;80(2):263–268. DOI: 10.1097/00000539-199502000-00011.

18. Chinn WM, Zavala DC, Ambre J. Plasma levels of lidocaine following nebulized aerosol administration. Chest 1977;71(3):346–348. DOI: 10.1378/chest.71.3.346.

19. Laurito CE, Baughman VL, Becker GL, et al. Effects of aerosolized and/or intravenous lidocaine on hemodynamic responses to laryngoscopy and intubation in outpatients. Anesth Analg 1988;67(4):389–392.

20. Bunting HE, Kelly MC, Milligan KR. Effect of nebulized lignocaine on airway irritation and haemodynamic changes during induction of anaesthesia with desflurane. Br J Anaesth 1995;75(5):631–633. DOI: 10.1093/bja/75.5.631.

21. Kumar A, Seth A, Prakash S, et al. Attenuation of the hemodynamic response to laryngoscopy and tracheal intubation with fentanyl, lignocaine nebulization, and a combination of both: a randomized controlled trial. Anaesth Essays Res 2016;10(3):661–666. DOI: 10.4103/0259-1162.191113.

22. Meng YF, Cui GX, Gao W, et al. Local airway anesthesia attenuates hemodynamic responses to intubation and extubation in hypertensive surgical patients. Med Sci Monit 2014;20:1518–1524. DOI: 10.12659/MSM.890703.

23. Jokar A, Babaei M, Pourmatin S, et al. Effects of intravenous and inhaled nebulized lignocaine on the hemodynamic response of endotracheal intubation patients: a randomized clinical trial. Anesth Essays Res 2018;12(1):159–164. DOI: 10.4103/aer.AER_75_17.

24. Ganesan P, Balachander H, Elakkumanan LB. Evaluation of nebulized lignocaine versus intravenous lignocaine for attenuation of pressor response to laryngoscopy and intubation. Curr Med Issues 2020;18(3):184–188. DOI: 10.4103/cmi.cmi_50_20.

25. Acharya N, Routray D. A prospective randomized study of efficacy of clonidine in attenuating haemodynamic response to laryngoscopy and tracheal intubation. Ann Int Med Den Res 2017;3(2):AN30–AN34.

26. Chhatrapati S, Shitole AB. Efficacy of intravenous clonidine to attenuate cardiovascular stress response to laryngoscopy and tracheal intubation–a prospective randomized double blind study. Int J Cont. Med Res 2016;3(5):1462–1467.


© Jaypee Brothers Medical Publishers. 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.